Harvard Health Letter

Niacin into the void

Failure of HDL cholesterol drug may be this B vitamin's big chance.

Drug companies have been frantically looking for an agent to increase HDL levels. It's a worthy goal — although the fact that their patents on the LDL-lowering statin drugs are expiring may have helped animate the search.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »